Non-hydropic intrauterine fetal death more than five months after primary parvovirus B19 infection
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378942336 | ||
| 003 | CHVBK | ||
| 005 | 20180305123655.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e20040301xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/JPM.2004.032 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/JPM.2004.032 | ||
| 245 | 0 | 0 | |a Non-hydropic intrauterine fetal death more than five months after primary parvovirus B19 infection |h [Elektronische Daten] |c [Margareta Nyman, Lottie Skjöldebrand-Sparre, Kristina Broliden] |
| 520 | 3 | |a Aims: Clinical follow-up of possible fetal complications associated with maternal parvovirus B19 infection is usually recommended during the 2-3 months after primary infection. Results: A case of late intrauterine fetal death associated with at least 5 months of maternal parvovirus B19 viremia and in the presence of B19 IgG and IgM is described. Conclusions: The time of clinical and laboratory followup after maternal parvovirus B19 infection may need to be revised if prolonged viremia is more common than previously described. | |
| 540 | |a © Walter de Gruyter | ||
| 690 | 7 | |a Human reproduction, growth & development |2 nationallicence | |
| 690 | 7 | |a Gynaecology & obstetrics |2 nationallicence | |
| 690 | 7 | |a Paediatric medicine |2 nationallicence | |
| 690 | 7 | |a Fetal |2 nationallicence | |
| 690 | 7 | |a infection |2 nationallicence | |
| 690 | 7 | |a intrauterine death |2 nationallicence | |
| 690 | 7 | |a parvovirus B19 |2 nationallicence | |
| 700 | 1 | |a Nyman |D Margareta |u Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden. |4 aut | |
| 700 | 1 | |a Skjöldebrand-Sparre |D Lottie |u Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden. |4 aut | |
| 700 | 1 | |a Broliden |D Kristina |u Department of Medicine at Karolinska University Hospital, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden. |4 aut | |
| 773 | 0 | |t Journal of Perinatal Medicine |d Walter de Gruyter |g 32/2(2004-03-01), 176-178 |x 0300-5577 |q 32:2<176 |1 2004 |2 32 |o jpme | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/JPM.2004.032 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/JPM.2004.032 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Nyman |D Margareta |u Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Skjöldebrand-Sparre |D Lottie |u Division of Obstetrics and Gynecology, Karolinska Institutet, Danderyd Hospital, Danderyd, Sweden |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Broliden |D Kristina |u Department of Medicine at Karolinska University Hospital, Infectious Diseases Unit, Karolinska Institutet, Stockholm, Sweden |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Journal of Perinatal Medicine |d Walter de Gruyter |g 32/2(2004-03-01), 176-178 |x 0300-5577 |q 32:2<176 |1 2004 |2 32 |o jpme | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 986 | |a SWISSBIB |b 378942336 | ||
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||